In June 2025, Eli Lilly reported Phase III ACHIEVE-1 Survodutide (BI 456906): Boehringer Ingelhium Survodutide (BI 456906) is a GCGR/GLP1 dual agonist being developed by Boehringer Ingelhium
For post-GLP-1 patients who have achieved significant weight loss but desire enhanced muscle definition, HD liposuction can create the appearance of a six-pack or more defined waistline
Research-grade materials lack regulatory oversight for human use, potentially compromising both safety and efficacy
Best polyphenol sources: Berries (blueberries, raspberries, blackberries) Dark leafy greens (spinach, kale) Artichokes, olives, onions Green tea, black tea, and coffee Dark chocolate and unrefined cocoa Spices like cinnamon, turmeric, ginger 5
TMAO biosynthesis consists of two steps